Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Espie

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Frontiers in Immunology|October 3, 2022
New insights into CAR T cell-mediated killing of tumor cellsDavid Espie, Emmanuel Donnadieu
Seminars in Immunopathology|January 23, 2023
CAR T-cell behavior and function revealed by real-time imagingDavid Espie, Emmanuel Donnadieu
Methods in Molecular Biology (Clifton, N.J.)|April 27, 2023
Live Imaging of CAR T Cell Ca<sup>2+</sup> Signals in Tumor Slices Using Confocal MicroscopyDavid Espie, Sarah Barrin, Irena Rajnpreht, et al.
Science Translational Medicine|September 28, 2022
CAR T cells targeting <i>Aspergillus fumigatus</i> are effective at treating invasive pulmonary aspergillosis in preclinical modelsMichelle Seif, Tamara Katharina Kakoschke, Frank Ebel, et al.
Journal for Immunotherapy of Cancer|May 16, 2022
Time 2EVOLVE: predicting efficacy of engineered T-cells - how far is the bench from the bedside?Sonia Guedan, Maik Luu, Delphine Ammar, et al.
Journal for Immunotherapy of Cancer|May 16, 2022
Time to evolve: predicting engineered T cell-associated toxicity with next-generation modelsEmmanuel Donnadieu, Maik Luu, Miriam Alb, et al.
Blood|January 6, 2026
Harnessing the CD2 axis to broaden and enhance the efficacy of CAR T-cell therapiesAlberto Carturan, Mathew G Angelos, Puneeth Guruprasad, et al.
Science Translational Medicine|February 4, 2026
Chimeric antigen receptor T cells against the IGHV4-34 B cell receptor specifically eliminate neoplastic and autoimmune B cellsIvan J Cohen, Audrey C Bochi-Layec, Jean Lemoine, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Frontiers in Immunology|October 3, 2022
New insights into CAR T cell-mediated killing of tumor cellsDavid Espie, Emmanuel Donnadieu
Seminars in Immunopathology|January 23, 2023
CAR T-cell behavior and function revealed by real-time imagingDavid Espie, Emmanuel Donnadieu
Methods in Molecular Biology (Clifton, N.J.)|April 27, 2023
Live Imaging of CAR T Cell Ca<sup>2+</sup> Signals in Tumor Slices Using Confocal MicroscopyDavid Espie, Sarah Barrin, Irena Rajnpreht, et al.
Science Translational Medicine|September 28, 2022
CAR T cells targeting <i>Aspergillus fumigatus</i> are effective at treating invasive pulmonary aspergillosis in preclinical modelsMichelle Seif, Tamara Katharina Kakoschke, Frank Ebel, et al.
Journal for Immunotherapy of Cancer|May 16, 2022
Time 2EVOLVE: predicting efficacy of engineered T-cells - how far is the bench from the bedside?Sonia Guedan, Maik Luu, Delphine Ammar, et al.
Journal for Immunotherapy of Cancer|May 16, 2022
Time to evolve: predicting engineered T cell-associated toxicity with next-generation modelsEmmanuel Donnadieu, Maik Luu, Miriam Alb, et al.
Blood|January 6, 2026
Harnessing the CD2 axis to broaden and enhance the efficacy of CAR T-cell therapiesAlberto Carturan, Mathew G Angelos, Puneeth Guruprasad, et al.
Science Translational Medicine|February 4, 2026
Chimeric antigen receptor T cells against the IGHV4-34 B cell receptor specifically eliminate neoplastic and autoimmune B cellsIvan J Cohen, Audrey C Bochi-Layec, Jean Lemoine, et al.
Pageof 1